English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Zendy Plus

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Zendy Tools

Zendy Open

The  GINS  complex associates with cell division cycle (Cdc) protein 45 and mini‐chromosome maintenance (Mcm) proteins 2–7 to form the Cdc45–Mcm– GINS  ( CMG ) complex, which is essential for  DNA  duplication. One member of the  GINS  complex is Psf3. We previously found that increased Psf3 expression was strongly associated with poor survival in lung adenocarcinoma. Here, we investigated the role of Psf3 expression in non‐small‐cell lung cancer ( NSCLC ). We verified Psf3 expression in human  NSCLC  tissues (180 patients) and cell lines. Immunohistochemical analysis revealed that the overexpression of Psf3 was significantly associated with vessel invasion ( P  = 0.016), lymphatic invasion ( P  = 0.002), and pleural invasion ( P  = 0.036). The overall survival rate in patients with Psf3 overexpression was significantly lower than that in patients without Psf3 overexpression ( P  = 0.006). Multivariate survival analysis revealed Psf3 expression to be an independent risk factor for an unfavorable outcome ( P  = 0.049). A proximal ligation assay showed interactions between Psf3 and other  CMG  components (such as Mcm2 and Cdc45) in both  NSCLC  specimens and cell lines, indicating that Psf3 acted as the  CMG  complex, which could lead to excessive proliferation. Knockdown of Psf3 inhibited the proliferation of both cell lines by delaying the S phase, which revealed that Psf3 played an important role in cancer proliferation. Thus, Psf3 acted as the  CMG  complex, promoting excessive proliferation. These results suggest that Psf3 inhibition might be a therapeutic target for  NSCLC  with Psf3 overexpression.

Significant role of Psf3 expression in non‐small‐cell lung cancer